Table 4.
The clinical characteristics of COVID-19 patients
| Characteristics | Mild (n=56) | Severe (n=16) | 5P value |
|---|---|---|---|
| 1Age (Mean ± SD) | 47±16.44 | 60±16.88 | 0.0153 |
| Subgroup (%) | |||
| ≤65 years old | 87.50 | 62.50 | |
| >65 years old | 12.50 | 37.50 | |
| 2Coexisting conditions (%) | |||
| Hypertension | 14.30 | 50.00 | 0.009262 |
| Diabetes | 10.20 | 25.00 | ns |
| Coronary heart disease | 6.10 | 25.00 | ns |
| Cerebrovascular disease | 6.10 | 31.30 | 0.026548 |
| Chronic obstructive pulmonary disease | 1.80 | 6.30 | ns |
| Chronic renal disease | 0 | 6.30 | ns |
| Cancer | 5.40 | 6.30 | ns |
| Tuberculosis | 1.80 | 0 | ns |
| 3Current smoker (%) | 17.90 | 16.67 | ns |
| 4Positive culture on the same day plasma collected | |||
| Bacterial (%) | 5.40 | 25.00 | ns |
| Fungal (%) | 1.80 | 12.50 | ns |
Note: 1 Age: the mean age of 56 mild patients and 16 severe patients.
2 Coexisting conditions (%): The percentage of coexisting diseases in mild and severe cases. Coexisting conditions were recorded in 49 mild patients and 16 severe patients.
3 Current smoker (%): The percentage of smokers in 49 mild patients and 16 severe patients.
4 Positive culture on the same day plasma: The percentage of fungi and bacteria detected in plasma of mild and severe patients.
5 P value: The incidence of clinical disease, which was different between mild and severe patients, was examined by Fisher's exact test.